Japanese drugmakers open 'libraries' in $100 million health project
LONDON (Reuters) - Five top Japanese drug companies are to open their "libraries" of experimental compounds to scrutiny by scientist...
Read More »LONDON (Reuters) - Five top Japanese drug companies are to open their "libraries" of experimental compounds to scrutiny by scientist...
Read More »By Kathryn Doyle NEW YORK (Reuters Health) - They are a fad that refuses to fade, but no solid evidence exists to show whether or no...
Read More »By Genevra Pittman NEW YORK (Reuters Health) - Losing weight may ease psoriasis and improve quality of life for some overweight peop...
Read More »
By Ben Hirschler LONDON (Reuters) - GlaxoSmithKline is betting on a new vaccine technology based on chimpanzee viruses by acquiring ...
Read More »
PARIS (Reuters) - France's health regulator said on Thursday it would comply with the European Commission if it ruled that Bayer acn...
Read More »By Padraic Halpin DUBLIN (Reuters) - Irish drugmaker Elan will lay out an alternative strategy if shareholders reject a string of pl...
Read More »
By P.J. Huffstutter and Lisa Baertlein CHICAGO/LOS ANGELES (Reuters) - When Smithfield Foods Inc. quietly weaned the first of its pi...
Read More »By Susan Heavey WASHINGTON (Reuters) - Immigrants for years have paid far more into Medicare's coffers than they have pulled out, ef...
Read More »By Kate Kelland LONDON (Reuters) - Long-term high-dose use of painkillers such as ibuprofen or diclofenac is "equally hazardous" in ...
Read More »By Sharon Begley NEW YORK (Reuters) - Employees will be eligible for significantly lower premiums on the health insurance they buy t...
Read More »